Ontology highlight
ABSTRACT:
SUBMITTER: Dehvari N
PROVIDER: S-EPMC6177610 | biostudies-literature | 2018 Nov
REPOSITORIES: biostudies-literature
Dehvari Nodi N da Silva Junior Edilson Dantas ED Bengtsson Tore T Hutchinson Dana Sabine DS
British journal of pharmacology 20180118 21
The β<sub>3</sub> -adrenoceptor was initially an attractive target for several pharmaceutical companies due to its high expression in rodent adipose tissue, where its activation resulted in decreased adiposity and improved metabolic outputs (such as glucose handling) in animal models of obesity and Type 2 diabetes. However, several drugs acting at the β<sub>3</sub> -adrenoceptor failed in clinical trials. This was thought to be due to their lack of efficacy at the human receptor. Recently, mirab ...[more]